We developed a blood spot test for syphilis antibody using enzyme-linked immunosorbent assay (ELISA) 
The incidence of infectious syphilis in the United States has increased sharply in recent years (16, 24, 26) . Increases have been reported for cities, in association with human immunodeficiency virus (HIV) infection, and among opiate and cocaine drug abusers, prostitutes, and newborns (6, 7, 12, 14, 22, 23) . Public health efforts to contain this outbreak by identifying the prevalence and distribution of infection and by diagnosing infectious disease early are based primarily on serologic tests (4, 5, 17, 26) .
Protocols for serologic tests for syphilis dictate nontreponemal cardiolipin antigen screening tests, supplemented when indicated by confirmatory treponemal-antibody tests (10, 13) . Nontreponemal-antibody assays using enzyme-linked immunosorbent assay (ELISA) serochemistry have been described elsewhere (20, 21, 28) . These new techniques show a sensitivity and specificity comparable to those of flocculation procedures (26a, 28) . In addition, these assays offer the distinct advantages of instrument-objective test readings and formats suitable for manual or automated screening of large numbers of specimens.
The increase in infectious syphilis, particularly in congenital disease, and the application of ELISA technology to screening tests suggest the use of ELISA for detecting nontreponemal antibody in dried blood spots. Blood spots have been found comparable to serum or plasma in studies of a number of infectious disorders: rubella, hepatitis, HIV disease, and most recently, yaws (1, 9, 27) . Moreover, on the basis of detection of passively transferred antibody in blood spots obtained from newborns, HIV ELISAs confirmed by Western blot (immunoblot) assays indicate the prevalence of HIV in childbearing women and estimate the number of infected children in the general population (8, 11, 19) .
A spot test for syphilis could be useful for studies of syphilis in childbearing women and could identify infants who may be infected (26b) . The test could be used for young children, the elderly, or others, such as intravenous drug abusers, for whom venipuncture may be problematic. Finally, it could be useful when low-cost specimen collection and transport are imperative.
We developed a nontreponemal-antibody ELISA for screening blood spots Ontario, Canada). Serum or plasma at an initial dilution of 1/20 in PBS (pH 7.2), or fluid eluted from dried blood spots at an equivalent concentration, is suitable for testing. Twenty microliters of diluted specimen was mixed with 30 ,u of 1.6x E-1 dilution buffer (Calypte Biomedical, Berkeley, Calif.) for a final dilution of 1/50 in the test plate well and incubated for 60 min at room temperature (RT). Each plate was washed six times (two cycles of three washes each) with 1.275% saline in an automated plate washer (Du Pont, Wilmington, Del.). Fifty microliters of an optimum concentration of horseradish peroxidase-conjugated F (ab')2 rabbit anti-human immunoglobulin G (DAKO, Carpinteria, Calif.) in PBS containing 1% bovine serum albumin was added, and the plates were incubated for 60 min at RT. After a second series of six washes, 50 ,u of the substrate 2,2'-azino-di-(3-ethyl)benzothiazoline-6-sulfonic acid) (ABTS; 50 mg/100 ml in buffer containing disodium hydrogen peroxide [Boehringer Mannheim, Indianapolis, Ind.]) was added. After 45 min of incubation at RT, the plates were swirled to ensure even distribution of converted substrate, and the A414 was read versus an air blank in an automated plate reader (Du Pont Test specimens. All patient identifiers were removed from all study sera or blood spots before experimental tests for syphilis.
(i) Serum. Aliquots were obtained from serum specimens after completion of serodiagnostic tests at the Wadsworth Center and from plasma specimens after completion of blood donor tests at the American Red Cross Greater Upstate New York Blood Services Center. The specimens were from four groups: reagin and treponemal-antibody test-reactive sera (n = 309), RPR-nonreactive blood donors (n = 92), sera from patients with documented stages of syphilis (n = 54), and biologic false-positive (reagin test-reactive and treponemal test-nonreactive) sera (n = 43). The specimens were tested after storage at 5°C for not more than 6 days or after storage at -20 or -70°C.
(ii) Blood spots. Whole blood in EDTA anticoagulant was obtained from individual donors within 2 days of collection. To determine the spot test's specificity and to establish normal background values, nonreactive spots were prepared by adding 50 pl of whole blood from each of 411 RPRnonreactive donors to the 1/2-in. targets of filter paper cards and air drying the spots at RT for 24 to 72 h. To test relative sensitivity, a measured volume of plasma was removed from type 0 normal donor blood and replaced with an equal volume of serum from one of 25 reagin test-reactive (titer, 4 to 32), treponemal test-reactive specimens. After mixing, blood spots were prepared as described above for nonreactive spots. The final RPR titer of the spiked blood was subsequently established by a test of serum recovered from the donor blood-reactive serum mixture.
Surplus newborn-blood spot specimens were obtained from the Wadsworth Center after all screening tests had been completed. Specimens included spots obtained from (i) 15 RPR-nonreactive and 35 RPR-reactive infants born to confirmed seropositive women, (ii) 219 infants born in geographic regions designated low-prevalence areas on the basis of the epidemiology of early infectious and congenital syphilis in New York State (18) , and (iii) infants (599 blood spots) born within a defined period in an urban hospital with a relatively high prevalence of congenital syphilis. For comparison with the last collection, maternal serum was obtained from the same hospital for 499 births occurring in the same period.
Newborn-blood spots retained at room temperature were tested within 24 days of collection. Spots held for longer times and control spots were stored for up to 90 days at 5°C, and for longer times at -20°C, in gas-impermeable plastic bags (Bitran Saranex-Series S; American Scientific Products, Pittsburgh, Pa.) with desiccant (Sorb-it; United Desiccants-Gates, Camden, N.J.) (9) .
Reproducibility. The distribution of results of single tests of spots prepared from spiked whole blood and quantitative flocculation tests of the plasma recovered from the spiked blood is shown in Fig. 3 . The sensitivity of the spot test with this set of Results obtained by retesting specimens after 6 months of storage at -20°C were comparable to those found after storage for 10 days at 5°C. There were no qualitative differences; that is, spots made with blood supplemented with known reactive sera were reactive, while donor spots were nonreactive. The means of absorbance values obtained by comparison of 25 reactive spots were 0.485 after 6 months of storage and 0.525 after 10 days of storage. For the 50 nonreactive donor spots, the corresponding values were 0.179 and 0.171.
DISCUSSION
It was essential, in developing the spot test, to separate the unique high background inherent in dried blood specimens from the reactivity specific to low antibody concentrations. Techniques used in other spot tests include detergents to suspend immunoglobulin aggregates in elution fluids and thus reduce nonspecific adsorption to test plates and prior addition of proteins such as bovine serum albumin or fetal calf serum to block plate surfaces not occupied by antigens. These measures are clearly successful with tests using protein antigens. Detergents, however, solubilize and detach cardiolipin-lecithin-cholesterol (CLC) antigen complexes from plates, and proteins are of limited effectiveness in blocking spaces among the adsorbed CLC. The spot test for syphilis uses (i) an optimum dilution of elution fluid to reduce the concentration of blood substances; (ii) E-1 dilution buffer A . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . There are a number of advantages to the spot test protocol. A phlebotomist is not required for specimen collection. Simple, inexpensive devices may be used for collecting specimens, spots may be transported at low cost, and large numbers of specimens may be stored in very little refrigerator or freezer space. Our findings are consistent with those of other studies (9) which indicate that, under laboratory conditions, antibodies in stored blood spots are stable.
Blood spots have been suggested as an excellent alternative to serum for HIV antibody tests when specimens are collected and stored under adverse tropical conditions (2) . It is important to add that eliminating blood tubes eliminates spill and aerosol dangers attributable to specimen handling operations such as uncapping, centrifuging, and separating or transferring serum. Finally, there is a marked reduction in the volume and weight of hazardous waste, whose disposal is costly.
The spot test protocol described in this report is suitable for larger-scale evaluation studies to establish its clinical and laboratory usefulness. The test presents an opportunity for seroprevalence and serodiagnostic programs. For seroprevalence, results of newborn screening tests would be especially helpful in estimating infection and disease in women and children, in describing demographic patterns associated with perinatal transmission, and in developing prevention and health care services. For serodiagnosis, screening tests of infants would help establish maternal infection and thus potential congenital disease, thereby reducing syphilis morbidity and health care costs by direct, early intervention. Finally, the spot test may make specimen collection and transport efficient and economical for special test programs.
